Brand Architecture within the Pharmaceutical Industry

The pharmaceutical industry is confronted with high competition, decreasing growth rates and a lower number of new ingredients. These changes raise the question whether the current innovation and product-oriented business model is the right one to face future challenges. One of the most important constituents of change is to be able to manage all pharmaceutical brands within the complex pharmaceutical customer network. This calls for a systematic pharmaceutical brand architecture approach, which is still missing today. For this purpose a highly diversified brand architecture process is affiliated and structured in general and transmitted to the pharmaceutical industry. The research purpose based on derived evaluation criteria for the constitution of pharmaceutical brand architecture is affiliated. It states extensive upcoming empirical research which deals with the quantitative evaluation of pharmaceutical brand architecture.